Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose extended-release lansoprazole (dexlansoprazole) + amoxicillin dual therapy for Helicobacter pylori infection
KCT0001758Phase 4Completed
- Sponsor
- Kyungpook National University Medical Center
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexlansoprazole, amoxicillin in Helicobacter pylori infection, sponsored by Kyungpook National University Medical Center. Started Dec 2015; status: completed.
02
Drugs
dexlansoprazoleamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on KCT0001758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001758.